Menao Guillén, S.; Pedrola, L.; Orellana, C.; Roselló, M.; Arruebo, M.; Lahuerta Pueyo, C.; Sobreviela Laserrada, M.; Marcos, B.; Pascual Mancho, J.; Cervera, J.V.;
et al. Clinical Utility of Opportunistic Genome-Wide cfDNA Prenatal Screening in Intermediate-Risk Pregnancies. Genes 2025, 16, 1344.
https://doi.org/10.3390/genes16111344
AMA Style
Menao Guillén S, Pedrola L, Orellana C, Roselló M, Arruebo M, Lahuerta Pueyo C, Sobreviela Laserrada M, Marcos B, Pascual Mancho J, Cervera JV,
et al. Clinical Utility of Opportunistic Genome-Wide cfDNA Prenatal Screening in Intermediate-Risk Pregnancies. Genes. 2025; 16(11):1344.
https://doi.org/10.3390/genes16111344
Chicago/Turabian Style
Menao Guillén, S., L. Pedrola, C. Orellana, M. Roselló, M. Arruebo, C. Lahuerta Pueyo, M. Sobreviela Laserrada, B. Marcos, J. Pascual Mancho, J. V. Cervera,
and et al. 2025. "Clinical Utility of Opportunistic Genome-Wide cfDNA Prenatal Screening in Intermediate-Risk Pregnancies" Genes 16, no. 11: 1344.
https://doi.org/10.3390/genes16111344
APA Style
Menao Guillén, S., Pedrola, L., Orellana, C., Roselló, M., Arruebo, M., Lahuerta Pueyo, C., Sobreviela Laserrada, M., Marcos, B., Pascual Mancho, J., Cervera, J. V., Tajada, M., & Quiroga, R.
(2025). Clinical Utility of Opportunistic Genome-Wide cfDNA Prenatal Screening in Intermediate-Risk Pregnancies. Genes, 16(11), 1344.
https://doi.org/10.3390/genes16111344